Vol 2017, No 3 (2017)

Table of Contents

Licensing

Immunomedics and Seattle Genetics enter into US$2 B Deal for Sacituzumab Govitecan Abstract pdf html
Natasha Piper
Allergan Partners with Assembly Bio to Gain Microbiome Gastrointestinal Development Programmes Abstract pdf html
Natasha Piper
Astellas Advances its Vaccine Ambitions with Affinivax’s Pneumococcal Candidate Abstract html pdf
Jasmine Kalsi
Akebia Broadens its Pipeline by Licensing J&J’s HIF-Based Portfolio Abstract html pdf
Jawala Prasad

Mergers & Acquisitions

Vertex Protects Cystic Fibrosis Franchise by Acquiring CTP-656 from Concert Abstract pdf html
Natasha Piper

Opinion & Analysis

IMS PharmaDeals: Review of 2016 Abstract pdf
Heather Cartwright & Taskin Ahmed


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.